Chromogenic Substrates

Chromogenic substrates are compounds that produce a visible color change when acted upon by specific enzymes. These substrates are widely used in diagnostic assays, biochemical research, and enzyme-linked immunosorbent assays (ELISAs) to detect and quantify enzyme activity. The color change allows for easy and rapid visual identification of enzyme reactions, making chromogenic substrates essential tools in laboratory analysis. At CymitQuimica, we provide a diverse selection of high-quality chromogenic substrates to support your research and diagnostic applications.

20
- 50
- 100
- 200

products per page. 790 products on this category.

Product data	Purity	Price range	Estimated delivery
N-Acetyl-5-bromo-3-indoxyl-2,3,4-tri-O-acetyl-β-D-glucuronic acid methyl ester REF: 3D-A-0702	Min. 98.0 Area-%	To inquire	Tue 17 Dec 24
5-Bromo-4-chloro-3-indoxyl-β-D-cellobioside REF: 3D-B-7110CAS: 177966-52-8	Min. 99.0 Area-%	To inquire	Tue 17 Dec 24
Aldol® 535 myo-inositol-1-phosphate, ammonium salt, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4778_P00CAS: 2484872-80-0	Min. 95.0 Area-%	To inquire	Tue 17 Dec 24
Aldol® 515 caprylate solution, 0.50 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4758_P00CAS: 2484873-04-1	Of Solute (Hplc) Min. 90.0 Area-%	To inquire	Tue 17 Dec 24
Aldol® 518 α-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4759_P00CAS: 2484873-05-2	Min. 95.0 Area-%	To inquire	Tue 17 Dec 24
Bronze-Gal REF: 3D-B-8935	- - -	To inquire	Tue 17 Dec 24
Aldol® 518 myo-inositol-1-phosphate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4760_P00CAS: 2484873-07-4	Min. 95.0 Area-%	To inquire	Tue 17 Dec 24
Aldol® 470 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4679_P00CAS: 1254798-13-4	Min. 95.0 Area-%	To inquire	Tue 17 Dec 24
5-Bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt REF: 3D-B-7404CAS: 212515-11-2	Min. 90.0 Area-%	To inquire	Tue 17 Dec 24
Aldol® 518 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4734_P00CAS: 2484872-89-9	Min. 95.0 Area-%	To inquire	Tue 17 Dec 24
Aldol® 458 acetate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4690_P00CAS: 2484872-51-5	Min. 95.0 Area-%	To inquire	Tue 17 Dec 24
Aldol® 470 nonanoate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4683_P00CAS: 2484872-50-4	Min. 95.0 Area-%	To inquire	Tue 17 Dec 24
5-Bromo-4-chloro-3-indoxyl-3-acetate REF: 3D-B-6244CAS: 3252-36-6	Min. 98 Area-%	To inquire	Tue 17 Dec 24
5-Bromo-4-chloro-3-indoxyl-N-acetyl-β-D-glucosaminide REF: 3D-B-7000CAS: 4264-82-8	Min. 99.5 Area-%	To inquire	Tue 17 Dec 24
5-Bromo-4-chloro-3-indoxyl caprylate REF: 3D-B-7100CAS: 129541-42-0	Min. 99 Area-%	To inquire	Tue 17 Dec 24
Aldol® 518 β-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4735_P00CAS: 2484872-90-2	Min. 95 Area-%	To inquire	Tue 17 Dec 24
Aldol® 458 nonanoate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4693_P00CAS: 2484872-52-6	Min. 98.0 Area-%	To inquire	Tue 17 Dec 24
5-Bromo-4-chloro-3-indoxyl sulfate, potassium salt REF: 3D-B-7600CAS: 6578-07-0	Min. 98.0 Area-%	To inquire	Tue 17 Dec 24
5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt trihydrate REF: 3D-B-7400CAS: 370100-64-4	Min. 99.0 Area-%	To inquire	Tue 17 Dec 24
Aldol® 495 acetate, Biosynth Patent: EP 2427431 and US 8940909 REF: 3D-A-4700_P00CAS: 2484872-59-3	Min. 95.0 Area-%	To inquire	Tue 17 Dec 24

1g		To inquire
5g		To inquire
250mg		To inquire
500mg		To inquire
2500mg		To inquire

1g		To inquire
50mg		To inquire
100mg		To inquire
250mg		To inquire
500mg		To inquire

Chromogenic Substrates

N-Acetyl-5-bromo-3-indoxyl-2,3,4-tri-O-acetyl-β-D-glucuronic acid methyl ester

Ref: 3D-A-0702

5-Bromo-4-chloro-3-indoxyl-β-D-cellobioside

Ref: 3D-B-7110

Aldol® 535 myo-inositol-1-phosphate, ammonium salt, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4778_P00

Aldol® 515 caprylate solution, 0.50 M in DMSO, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4758_P00

Aldol® 518 α-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4759_P00

Bronze-Gal

Ref: 3D-B-8935

Aldol® 518 myo-inositol-1-phosphate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4760_P00

Aldol® 470 β-D-galactopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4679_P00

5-Bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt

Ref: 3D-B-7404

Aldol® 518 β-D-glucopyranoside, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4734_P00

Aldol® 458 acetate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4690_P00

Aldol® 470 nonanoate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4683_P00

5-Bromo-4-chloro-3-indoxyl-3-acetate

Ref: 3D-B-6244

5-Bromo-4-chloro-3-indoxyl-N-acetyl-β-D-glucosaminide

Ref: 3D-B-7000

5-Bromo-4-chloro-3-indoxyl caprylate

Ref: 3D-B-7100

Aldol® 518 β-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4735_P00

Aldol® 458 nonanoate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4693_P00

5-Bromo-4-chloro-3-indoxyl sulfate, potassium salt

Ref: 3D-B-7600

5-Bromo-4-chloro-3-indoxyl-β-D-glucuronic acid, sodium salt trihydrate

Ref: 3D-B-7400

Aldol® 495 acetate, Biosynth Patent: EP 2427431 and US 8940909

Ref: 3D-A-4700_P00